Disruption of wild type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas

Point mutations at Arg132 of the cytoplasmic NADP+-dependent isocitrate dehydrogenase 1 (IDH1) occur frequently in gliomas and result in a gain-of-function to produce the “oncometabolite” D-2-hydroxyglutarate (D-2HG). The mutated IDH1 allele is usually associated with a wild type IDH1 allele (hetero...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Jin, Genglin, Reitman, Zachary J., Duncan, Chritopher G., Spasojevic, Ivan, Gooden, David M., Rasheed, B. Ahmed, Yang, Rui, Lopez, Giselle Y., He, Yiping, McLendon, Roger E., Bigner, Darell D., Yan, Hai
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3548957/
https://ncbi.nlm.nih.gov/pubmed/23204232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-12-2852
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares